Related Experiment Video
Updated: Jun 9, 2025

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
Published on: July 11, 2016
Clinical Outcomes and Molecular Characteristics of Bacteroides fragilis Infections
Bongyoung Kim1, Myungsook Kim2, Kyungwon Lee2,3
1Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
Abstract:
Bacteroides fragilis is the most common opportunistic anaerobic pathogen. In the absence of appropriate antimicrobial therapy, mortality rates associated with B. fragilis group infections can reach as high as 50%. Therefore, we aimed to elucidate the clinical characteristics and outcomes of B. fragilis infections and the molecular genetic characteristics of B. fragilis isolates. Forty B. fragilis clinical isolates were collected at Hanyang University Hospital between January 2022 and December 2023. Antimicrobial susceptibility was tested using the agar dilution method. Whole-genome sequencing was conducted using the Illumina platform (Illumina, San Diego, CA, USA). Various multilocus sequence types of B. fragilis were identified, including ST149 (N=4), ST11 (N=4), ST1 (N=3), ST21 (N=2), and ST157 (N=1). The insertion sequence (IS) IS1187, located upstream of cfiA, was associated with high-level carbapenem resistance in the ST157 isolate. B. fragilis toxin genes (bft ) were identified in 30% of isolates. The most common comorbidities were diabetes mellitus (26.5%) and non-metastatic cancer (23.5%). Five patients (14.7%) died within 30 days, and two (5.9%) deaths were directly attributable to B. fragilis infection. The emergence of high-level MIC carbapenem-resistant B. fragilis ST157 has led to caution in the presence of B. fragilis infections.
Insights
Bacteroides fragilis infections can be fatal. A study identified carbapenem-resistant B. fragilis ST157, highlighting the need for careful antimicrobial therapy and monitoring of this opportunistic pathogen.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- Bacteroides fragilis is a common opportunistic anaerobic pathogen.
- Infections can lead to high mortality rates (up to 50%) without proper antimicrobial treatment.
Purpose of the Study:
- To investigate the clinical features and outcomes of B. fragilis infections.
- To analyze the molecular genetic characteristics of B. fragilis isolates.
Main Methods:
- Collected 40 B. fragilis clinical isolates from Hanyang University Hospital (Jan 2022-Dec 2023).
- Performed antimicrobial susceptibility testing using agar dilution.
- Conducted whole-genome sequencing on the Illumina platform.
Main Results:
- Identified various multilocus sequence types (STs), including ST149, ST11, ST1, ST21, and ST157.
- Found IS1187 insertion sequence linked to high-level carbapenem resistance in the ST157 isolate.
- Detected B. fragilis toxin genes (bft) in 30% of isolates; common comorbidities included diabetes and cancer.
- Reported a 30-day mortality rate of 14.7%, with 5.9% directly attributed to B. fragilis infection.
Conclusions:
- The emergence of high-level carbapenem-resistant B. fragilis ST157 necessitates caution.
- Clinical and molecular characterization is crucial for managing B. fragilis infections.
More Related Videos
Related Concept Videos
Bacterial Phylum Bacteroidota
Bacterial Phylum Firmicutes
Applications of Molecular Taxonomy
Methods of Classification and Identification
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Bacterial Phylum Actinobacteria

